|Several healthcare focused hedge fund managers that were launched over the past few years are quickly making a name for themselves among the sector’s elite specialists. In fact, nearly 25% of the The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund List is now made up of emerging managers. |
In this week’s Hedge Fund Spotlight report, we look at Rock Springs Capital Management and Cormorant Asset Management, both of which were founded in 2013.
Rock Springs Capital is now ranked #26 on the Top Healthcare Hedge Fund List and #16 on the Top Emerging Hedge Fund Managers List , after having seen its assets jump by 7.1% quarter-over-quarter. The healthcare focused fund employs a global long/short equity investment strategy and is led by Kris Jenner, Mark Bussard and Graham McPhail. Prior to founding the firm, Jenner was the lead portfolio manager for T. Rowe Price's Health Sciences Fund, while Bussard and McPhail were research analysts at T. Rowe. During his final five years at T. Rowe, Jenner’s Health Sciences mutual fund outperformed 83% of its peers.
Cormorant Asset Management is now ranked #37 on the Top Healthcare Hedge Fund List and #32 on the Top Emerging Hedge Fund Managers List, after having seen its assets jump by an impressive 33.5% quarter-over-quarter. Cormorant was founded by Bihua Chen, who serves as the firm’s CEO and lead Portfolio Manager. The firm manages a global long/short public equity fund in healthcare, as well as a private equity/venture capital fund.
Prior to forming Cormorant Asset Management, Ms. Chen was a Venture Partner at Beacon Bioventures and Fidelity Biosciences, and before that she spent several years at Millennium Management, where she oversaw a portfolio of healthcare investments that peaked at $800M.
Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.